|
⚲
|
| Keyboard |
| LaBrosse Nicole
✚
|
|
|---|---|
| CIK # | 0001910662 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001910662] | |
| 4 | [0001910662] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| LaBrosse Nicole | |
| Halozyme Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-02-23 | Option exercise | 6,688 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-02-23 | Tax withheld | 3,608 | $70.64 | 254,869 |
|
Halozyme Therapeutics Inc HALO
Performance Stock Units · derivative
|
2026-02-23 | Option exercise | 6,688 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-02-20 | Option exercise | 5,332 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Restricted Stock Units · derivative
|
2026-02-20 | Option exercise | 5,332 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-02-20 | Tax withheld | 2,876 | $70.98 | 204,138 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-02-16 | Tax withheld | 7,273 | $79.44 | 577,767 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-02-16 | Option exercise | 5,329 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-02-16 | Tax withheld | 2,874 | $79.44 | 228,311 |
|
Halozyme Therapeutics Inc HALO
Restricted Stock Units · derivative
|
2026-02-16 | Option exercise | 5,093 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Performance Stock Units · derivative
|
2026-02-16 | Option exercise | 13,351 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Restricted Stock Units · derivative
|
2026-02-16 | Option exercise | 5,329 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-02-16 | Tax withheld | 2,747 | $79.44 | 218,222 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-02-16 | Option exercise | 13,351 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-02-16 | Option exercise | 5,093 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Performance Stock Units · derivative
|
2026-02-09 | Grant | 7,448 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Performance Stock Units · derivative
|
2026-02-09 | Grant | 5,167 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Performance Stock Units · derivative
|
2026-02-09 | Grant | 29,502 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Restricted Stock Units · derivative
|
2025-02-23 | Option exercise | 6,688 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2025-02-23 | Option exercise | 6,688 | $0.00 | |
| showing 20 of 97 most recent transactions | |||||